Hawaii-based LifeDNA is a healthtech company that aims to deliver personalized health and wellness insights to users globally. The company essentially wants to act as a dashboard for one’s health, where lifestyle, environment, biometric, and genetic data are integrated to create a holistic approach towards wellness.[Read More]
August 20, 2020
March 01, 2021
Open to Investors
Steve Markowitz - Chairman
In addition to his role at LifeDNA as the Chairman, Steve is a Honolulu-based impact investor focused on healthtech. Notably, he was the founding chairman and CEO of online loyalty marketing pioneer MyPoints.com, where he led the company to an IPO.xxxiv Under his leadership, the company grew from zero to 16 million consumer members.xxxv Additionally, Steve is also an inventor, with numerous issued U.S. patents in applied science.xxxvi Steve graduated with his MBA and BA in East Asian Languages from the University of California at Berkeley.
Cyril Moukarzel - CEO
Cyril started LifeDNA with the goal of making personalized medicine more accessible and helping everyday consumers live healthier. He has spent his career in startups, where he has focused on marketing and growth. Cyril has also been featured in publications such as CNN,xxxvii Forbes,xxxviii and Entrepreneur.xxxix He has a Bachelor of Commerce with a specialization in marketing from the University of Ottawa’s Telfer School of Management.
In connection with equity financing of at least $1 million, the Company has the option to convert the Crowd Note into non-voting preferred stock (Conversion Shares) at a price based on the lower of (A) a 20% discount to the price per share for Preferred Stock by investors in the Qualified Equity Financing or (B) the price per share paid on a $8 million or $10 million valuation cap. Please refer to the Crowd Note for a complete description of the terms of the Crowd Note, including the conversion provisions.
There are no additional research reports currently.